SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Conversant Bio Publishes Guide to Multiple Myeloma

E-Book Offers Researchers a Foundation of How the Disease Is Approached in the Real World

HUNTSVILLE, AL -- (Marketwired) -- 05/20/14 -- Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples, today announced it is publishing a guide about multiple myeloma. The e-book, Researcher's Guide to Multiple Myeloma: From the Real World to the Lab, is available as a free download at: http://www.conversantbio.com/multiple-myeloma-ebook

Multiple myeloma is a hematologic cancer that develops in the marrow of the long bones. Researchers are working toward a cure, and this new e-book provides them with a basic foundation of how the disease is approached in the real world. Features of the guide include:

  • How multiple myeloma is diagnosed
  • The different types of multiple myeloma
  • Labwork results of typical multiple myeloma patients in different stages
  • Treatments and side effects

Furthermore, the e-book also details the challenges faced when studying multiple myeloma, including obtaining quality bone marrow and blood samples that are integral for research.

"Researchers will benefit from this e-book when they are developing the criteria and parameters of their multiple myeloma research," says Luke Doiron, Chief Commercial Officer of Conversant Bio. "They will gain a new perspective on the disease that is outside the scope of the lab. And if they are in need of high-quality bone marrow and blood samples for their research, they can achieve access to such samples through Conversant Bio"

To download Researcher's Guide to Multiple Myeloma: From the Real World to the Lab, visit http://www.conversantbio.com/multiple-myeloma-ebook.

About Conversant Bio
Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting-edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S.-based clinical sites and an IRB-reviewed chain of custody quality control system, Conversant Bio provides the highest-quality samples on time and on budget. For additional information about Conversant Bio's services, visit the company's website at http://www.conversantbio.com.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.